This Week: Psychedelics startup X big pharma licensing deal At-home ketamine therapy company scores $23m Series A Psychedelics Research Review (March 2022) 2 events from our friends in D.C. and London P.S. We’re updating our Psychedelics Job Board. If you’re a psychedelics-related organisation, or an organisation hiring for psychedelics-related roles, get in touch to ensure your listings are…


Previous articlePsychedelic Research Bulletin: March 2022
Next articlePT313 – Christine Calvert, LCDC – Holotropic Breathwork, Ethics, and Dying To Ourselves